Leeward Investments LLC MA Sells 28,048 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Leeward Investments LLC MA reduced its holdings in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 376,680 shares of the company’s stock after selling 28,048 shares during the period. Prestige Consumer Healthcare comprises about 1.5% of Leeward Investments LLC MA’s investment portfolio, making the stock its 10th biggest position. Leeward Investments LLC MA owned 0.76% of Prestige Consumer Healthcare worth $29,415,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the business. Handelsbanken Fonder AB boosted its position in shares of Prestige Consumer Healthcare by 7.6% during the 4th quarter. Handelsbanken Fonder AB now owns 15,581 shares of the company’s stock valued at $1,217,000 after acquiring an additional 1,100 shares in the last quarter. Ieq Capital LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at about $239,000. New York State Common Retirement Fund boosted its position in shares of Prestige Consumer Healthcare by 5.1% during the 4th quarter. New York State Common Retirement Fund now owns 16,098 shares of the company’s stock valued at $1,257,000 after acquiring an additional 778 shares in the last quarter. Kestra Investment Management LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at about $27,000. Finally, Truist Financial Corp acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter valued at about $345,000. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock opened at $84.66 on Friday. Prestige Consumer Healthcare Inc. has a 1 year low of $62.35 and a 1 year high of $88.36. The firm’s 50 day moving average is $79.47 and its 200-day moving average is $76.56. The firm has a market capitalization of $4.19 billion, a price-to-earnings ratio of 19.83, a PEG ratio of 2.69 and a beta of 0.50. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

Several analysts have recently weighed in on the stock. Oppenheimer lifted their target price on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Canaccord Genuity Group boosted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a research report on Monday, December 9th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and a consensus target price of $92.60.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.